定量超声压缩波与剪切波衰减评估MASLD分级
本研究前瞻性纳入55例成人(13例健康志愿者、42例活检证实的MASLD患者),在同一超声采集上计算压缩波衰减(CWA)与剪切波衰减(SWA)。两者均与MRI-PDFF及肝组织学相关,联合应用可提高脂肪变性无创分级能力,减少对活检或MRI的依赖。
要点
- CWA与SWA在同一超声采集上即可获得,便于日常无创评估MASLD脂肪变性程度。
- CWA对脂肪变性分级S0 vs ≥S1的AUC达0.96,适合筛查有无脂肪变性。
- SWA对重度脂肪变性(≤S2 vs S3)的AUC达0.88,略优于CWA的0.75,可与CWA互补。
核心结论
- CWA与SWA反映不同的超声能量损失机制,CWA主要反映脂质相关散射和吸收,SWA主要反映黏弹性耗散。
- 两者均与MRI-PDFF和组织病理学显著相关,但继发性关联存在差异,联合使用可提高脂肪变性分级诊断效能。
研究设计与样本
- 前瞻性横断面研究,2020至2023年间纳入55例成人。
- 包括13例健康志愿者和42例活检证实的MASLD患者。
- 在同一超声采集数据上分别计算CWA与SWA。
- 参考标准为组织病理学和MRI质子密度脂肪分数(MRI-PDFF)。
关键影像表现/征象
- CWA与MRI-PDFF的相关系数为0.71,SWA与MRI-PDFF的相关系数为0.77,均为p<0.001。
- CWA与组织学相关性分别为脂肪变性0.66、炎症0.61、气球样变0.49、纤维化0.46。
- SWA与组织学相关性分别为脂肪变性0.74、炎症0.53、气球样变0.40、纤维化0.19。
诊断标准与关键数值
- 脂肪变性分级中,CWA与SWA的AUC分别为0.96与0.91(S0 vs ≥S1)。
- 脂肪变性分级中,CWA与SWA的AUC分别为0.85与0.87(≤S1 vs ≥S2)。
- 脂肪变性分级中,CWA与SWA的AUC分别为0.75与0.88(≤S2 vs S3,p<0.05)。
- MASH检测中,CWA与SWA的最高AUC分别为0.94与0.88。
- 多变量回归显示CWA对脂肪变性R²=0.54(p<0.001),SWA对脂肪变性R²=0.57(p<0.001)。
临床应用与阅片要点
- 对疑诊MASLD患者,可在同一超声检查中同时报告CWA与SWA,以互相补充脂肪变性分级信息。
- CWA适合作为初步筛查有无脂肪变性的参数,SWA在重度脂肪变性判断上可能更有帮助。
- 面对与MRI-PDFF一致性较高的CWA与SWA,可减少部分病例对MRI或肝活检的需求。
局限性
- 研究样本总量为55例,规模偏小。
- 未说明多中心还是单中心设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Ultrasound compression-wave attenuation (CWA) and shear-wave attenuation (SWA) quantify distinct mechanisms of ultrasonic energy loss in tissues and may provide complementary information for liver disease characterization. This study compares their diagnostic performance across the spectrum of metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis (MASH).
METHODS: In this prospective, cross-sectional study, 55 adults (13 healthy volunteers, 42 biopsy-proven MASLD patients) underwent ultrasound between 2020 and 2023. CWA and SWA were computed head-to-head on same acquisitions of participants. Correlations between CWA and SWA with histopathology and MRI-proton density fat fraction (PDFF) were assessed. Multivariate and area under the curve (AUC) analyses were performed.
RESULTS: Both CWA and SWA correlated strongly with MRI-PDFF (r = 0.71 and 0.77, p < 0.001). Correlations with histopathology were 0.66 (steatosis), 0.61 (inflammation), 0.49 (ballooning), and 0.46 (fibrosis) for CWA; and 0.74, 0.53, 0.40, and 0.19 for SWA. Multivariable regressions confirmed independent associations with steatosis (CWA R² = 0.54, p < 0.001; SWA R² = 0.57, p < 0.001). For steatosis grading, AUCs for CWA versus SWA were 0.96 vs. 0.91 (S0 vs. ≥S1), 0.85 versus 0.87 (≤S1 vs. ≥S2), and 0.75 versus 0.88 (≤S2 vs. S3; p < 0.05) and for MASH detection the highest AUCs for CWA versus SWA were 0.94 versus 0.88.
CONCLUSION: CWA and SWA capture complementary mechanisms of energy loss, CWA reflecting lipid-related scattering and absorption, SWA reflecting viscoelastic dissipation. Both correlate strongly with MRI-PDFF and histopathology, though they show distinct secondary associations. Their combined assessment within a single ultrasound examination improves noninvasive steatosis grading and may reduce reliance on biopsy or MRI.
引用
- Rafati, Van Houten, Najar, et al. Quantitative Ultrasound-Based Compression and Shear Wave Attenuation for Metabolic Dysfunction-Associated Steatotic Liver Disease Grading. Ultrasound Med Biol. 2026. PMID: 42629303. doi:10.1016/j.ultrasmedbio.2026.07.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。